☆ 4.7 Meeting Abstract

Ligelizumab for adolescent patients with CSU: first results from a dedicated Phase 2b study

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

Add to Collection

Journal

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Volume 149, Issue 2, Pages AB179-AB179

Publisher

MOSBY-ELSEVIER

Keywords

-

Categories

Allergy Immunology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.